SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
ERIS Lifesciences Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
540596 INE406M01024 203.3941378 ERIS 0.46 21,607.40 76.67 20.69 1
Quarters :
ParticularsSep 2025(Rs.Cr)Jun 2025(Rs.Cr)Mar 2025(Rs.Cr)
Gross Sales637.58567.90395.71
Other Operating Income12.9210.749.06
Other Income 23.5922.6816.75
Total Income674.09601.32421.52
Total Expenditure 353.62362.32283.80
PBIDT320.47239.00137.72
Interest 46.5045.1453.16
PBDT273.97193.8684.56
Depreciation39.3037.6043.38
Tax40.9127.178.51
Fringe Benefit Tax0.000.000.00
Deferred Tax44.1929.102.20
Reported Profit After Tax149.5799.9930.47
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item149.5799.9930.47
    
EPS (Unit Curr.)10.987.342.24
EPS (Adj) (Unit Curr.)10.987.342.24
Calculated EPS (Unit Curr.)10.987.342.24
Calculated EPS (Adj) (Unit Curr.)10.987.342.24
Calculated EPS (Ann.) (Unit Curr.)43.9329.378.95
Calculated EPS (Adj) (Ann.) (Unit Curr.)43.9329.378.95
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity13.6213.6213.62
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)50.2642.0834.80
PBDTM(%)42.9734.1421.37
PATM(%)23.4617.617.70